TG101209 analog 1
TG101209 analog 1 (Compound 8h) is an inhibitor for BUB1B with an IC50 of 10.36 μM. TG101209 analog 1 exhibits cytotoxicity (IC50 for Caki-1 is 1.347 μM), induce necrosis and apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis
Related Pathways
Apoptosis
Field of Research
Cancer
Purity
98.27
Solubility
DMSO : 350 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=CC(NC2=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=NC=C2C)=C1)(NC(C)(C)C)=O
Molecular Formula
C24H31N5O5S
Molecular Weight
501.60
References & Citations
[1]El Hafi M, et al., Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma. Eur J Med Chem. 2025 Jan 9;285:117247.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E2236-60-Biotin 200 µL
EMILIN1, NT (EMILIN-1, Elastin Microfibril Interface-located Protein 1, Elastin Microfibril Interfacer 1, EMI) (Biotin) discontinued
Ask
View Details 
C2264-03-ML750 100 µL
CD13 (Alanyl Aminopeptidase, Alanyl Membrane Aminopeptidase, Aminopeptidase M, gp150, Aminopeptidase N, ANPEP, APN, CD13 Antigen, hAPN, Lap 1, Lap1, Microsomal Aminopeptidase, Myeloid Plasma Membrane Glycoprotein CD13, p150, PEPN) (MaxLight 750) discontinued
Ask
View Details